|
HS Code |
905903 |
| Name | Cortisone |
| Chemical Formula | C21H28O5 |
| Drug Class | Corticosteroid |
| Molecular Weight | 360.44 g/mol |
| Cas Number | 53-06-5 |
| Mechanism Of Action | Reduces inflammation by suppressing immune response |
| Route Of Administration | Oral, injection |
| Indications | Arthritis, allergies, skin diseases, adrenal insufficiency |
| Side Effects | Weight gain, mood changes, high blood pressure |
| Contraindications | Systemic fungal infections, hypersensitivity |
| Pregnancy Category | C |
| Half Life | 18-36 hours |
As an accredited Cortisone factory, we enforce strict quality protocols—every batch undergoes rigorous testing to ensure consistent efficacy and safety standards.
| Packing | Cortisone is packaged in amber glass vials containing 100 mg sterile powder, sealed with a rubber stopper and aluminum cap. |
| Shipping | Cortisone should be shipped in a well-sealed container, protected from light and moisture. During transport, it must be kept at controlled room temperature (15–30°C). Comply with all relevant regulations for pharmaceuticals. Ensure the package is labeled appropriately, and handle with care to avoid contamination or degradation of the compound. |
| Storage | Cortisone should be stored at room temperature, typically between 20°C to 25°C (68°F to 77°F), in a tightly closed container. It must be kept away from moisture, heat, direct light, and incompatible substances. Store in a well-ventilated area, in original packaging, and out of reach of children and pets to maintain its stability and effectiveness. |
Competitive Cortisone prices that fit your budget—flexible terms and customized quotes for every order.
For samples, pricing, or more information, please contact us at +8615365186327 or mail to sales3@ascent-chem.com.
We will respond to you as soon as possible.
Tel: +8615365186327
Email: sales3@ascent-chem.com
Flexible payment, competitive price, premium service - Inquire now!
Over the past several decades in the chemical manufacturing field, cortisone has consistently stood out as a cornerstone compound for both industrial and medical applications. At our facility, the sustained production and improvement of cortisone reflect both experience and an ongoing commitment to high standards. Cortisone belongs to the corticosteroid family, more precisely a glucocorticoid, which means it participates in countless biological processes. The scientific journey leading to mass production required careful attention to purification, stability, and scalability. Handling every nuance in the manufacturing process ensures the quality and consistency expected by researchers, pharmaceutical partners, and healthcare providers alike.
When handling cortisone in bulk, purity is not an abstract ideal; it ties directly to how well formulations perform across dosage forms. In our facility, the cortisone synthesis process begins with selection of raw materials by a procurement team that knows the pitfalls low-grade inputs can introduce. Using proprietary refining techniques, we target impurities that even high-end analytical labs sometimes miss in standard assays. Every batch receives thorough analysis through validated chromatography and spectroscopy procedures—a testament to our constant vigilance.
Our manufacturing catalog includes several cortisone models, tailored as either base cortisone or cortisone acetate depending on the end use. Base cortisone serves as a starting point for bulk synthesis, while the acetate ester unlocks more predictable pharmacokinetics in therapeutic applications. The physical specifications, such as crystalline forms and particle size distribution, are selected in consultation with partners who know what final formulations need. Specifications remain constant, batch after batch, supported by document trails showing impurity profiles and stability under heat, light, and humidity stress.
Experience over the years has taught us that inconsistency in crystalline habit or solvent residues leads to trouble further down the pipeline. For cortisone, our team maintains tight water-content controls at every processing stage. Particle size variation can affect bioavailability and dosing in both topical creams and oral tablets. Direct input from formulation scientists drives the way we tune milling and drying parameters—not from theoretical models, but through feedback on solubility and mechanical processing faced in real manufacturing settings.
Cortisone finds its primary demand in drug manufacturing, especially in anti-inflammatory therapies and adrenal insufficiency treatments. Over time, we have seen an evolution in the kinds of formulations developed by our customers. Initially, demand focused on basic oral tablets and injectable suspensions; now, sustained-release and topical forms play a much larger role. Both large pharmaceutical firms and those developing orphan drug therapies expect raw cortisone of the same rigor regardless of batch size. Every deviation in specification—particle size, moisture content, trace solvents—directly influences the stability and performance of finished medicines.
Beyond direct pharmaceutical preparation, cortisone also supports research into autoimmune and metabolic disorders. Academic laboratories often choose cortisone produced with the least possible variation between lots. Supporting large multi-site studies requires confidence that biological results stem from the compound under investigation, not minute differences in synthesis from batch to batch. In difficult or expensive research protocols, confidence in the raw chemical's provenance saves time, money, and avoids ambiguous data.
Practical knowledge of how cortisone differs from other corticosteroid compounds matters for anyone planning to use large commercial batches. Over countless customer projects, we’ve documented cortisone’s slower receptor binding and lower mineralocorticoid activity compared to prominent alternatives such as hydrocortisone or prednisone. These molecular-level distinctions translate to different profiles in applications involving skin, mucous membranes, or systemic administration. For topical applications, cortisone’s relative mildness reduces the risk of over-suppressing local immune responses. In the hands of skilled formulators, this chemistry supports products that bring symptomatic relief without introducing harsher side effects.
From a production perspective, cortisone’s chemical stability differs from more oxidized corticosteroids. It handles processing at ambient conditions better. Predictable shelf life and steady release profiles mean less wastage and fewer product recalls. Over time, this stability simplifies downstream manufacturing steps—whether blending into ointments or integrating into tablets. Pharmaceutical partners have less need for complex preservative systems or artificial stabilizers when starting from cortisone made to this standard.
Producing cortisone today isn’t only a matter of maintaining inherited processes. Growing regulation concerning solvents, process safety, and environmental impact changes the equation every year. In response, our plant continually updates containment, air handling, and solvent-recycling systems. Most cortisone production sites globally now adopt greener chemistry recommendations, moving toward non-chlorinated solvents where possible and minimizing hazardous waste streams. The old days of uncontrolled releases and poor solvent scrubbing are over. These investments do not come cheap, but strict adherence protects both surrounding communities and the environment.
We’ve observed a growing scrutiny from regulators—especially in areas of trace contaminants, cross-contamination, and worker exposure. Every failed inspection or recall reported in the industry reinforces the value of making investments before problems arise. Newer spectroscopic tools help us catch sources of contamination before they impact outgoing products. High-performance liquid chromatography and LC-MS analysis now catch sub-ppm impurities old protocols might miss. We train all staff to recognize risks and encourage reporting of any deviations, not simply following procedures by rote.
Cortisone requires rigorous safety and occupational health protocols throughout production and packaging. Training for staff covers not only immediate risks from dust or contact, but long-term cumulative health impacts reported in academic literature. Our plant draws on decades of industrial hygiene experience, rotating staff and automating processes prone to accidental release or exposure. Dust containment never receives short shrift here. Using enclosed reactors, vacuum transfer, and filtered air extraction marks a firm break with past reliance on open trays and hand-scooping material.
In facility design, we incorporate real-world feedback from operators encountering process upsets. Emergency response drills use probable, not just theoretical, scenarios. We tune our safety policies based on near-misses and process deviations actually witnessed on shift. Lessons learned get written back into process guides that all new staff receive on their first day. This approach, rooted in day-to-day plant reality, minimizes accidents and strengthens trust both among the workforce and with regulatory inspectors.
Serving the pharmaceutical and research industries for decades, we’ve witnessed how cortisone requirements evolve as therapies change. Partners now demand ever more rigorous documentation—comprehensive certificate of analysis, detailed traceability of raw materials, and real-time batch monitoring data. Modern expectations do not tolerate stock responses about standard quality; each customer, from the smallest compounding pharmacy to the largest multinational, wants evidence to match every claim. To meet these needs, we maintain an open channel for technical queries, and we offer on-site support whenever a customer’s process meets a snag.
Product recalls or failed batches downstream prompt us to review not only our last delivery, but adjacent lots and upcoming production schedules. Transparency and full disclosure may slow paperwork in the short term but prevent costly mistakes for everyone involved. This willingness to work alongside quality control teams and R&D departments builds trust that spans decades. As colleagues rather than mere suppliers, we respond to requests for specialized particle sizes or customized packaging rather than insisting only on catalog offerings.
The value of cortisone isn’t limited to finished pharmaceuticals. In our experience, university labs, hospital research centers, and even industrial R&D functions draw on cortisone in pursuit of new treatments and broader biological insights. These teams depend on uninterrupted supply and reproducible purity to move from bench to bedside. Whether optimizing animal study protocols or developing new biosynthetic pathways for corticosteroid production, dependable cortisone input prevents wasted time and failed experiments.
We’ve observed that early engagement with research groups pays off in smoother technology transfer down the line. Some of the highest-impact treatments in autoimmune disease and inflammatory medicine began with hesitant requests for pilot-scale cortisone. Through long-term supply relationships and open technical exchange, we bridge the gap between raw chemical and therapeutic breakthrough. In many cases, our production chemists collaborate directly with researchers to adjust process parameters—offering exact gradation of crystalline form or customized impurities profile to match experimental protocols.
Manufacturing quality cortisone demands constant vigilance—routine never replaces confirmation. To protect end users, our plant maintains redundant monitoring systems, cross-validating methods and regularly reviewing analytical data. Regulatory audits and customer visits aren’t viewed as threats but as opportunities to validate processes and invite constructive criticism. This transparency sustains long-term relationships far better than flashy marketing or unsupportable claims.
Each gram of cortisone shipped under our name passes through multiple checkpoints, backed by clear documentation of every step. The real-world outcome is straightforward: fewer customer complaints, consistent downstream processing, and less time resolving avoidable errors. Seasoned customers appreciate the predictability this brings year after year; new partners see the difference in shorter turnaround for custom requests or regulatory submissions.
Consistent manufacturing turns out to be the single most important factor for cortisone beyond cost or raw material availability. Every aspect—from humidity control in storage, to solvent selection in synthesis, to packaging—affects both stability and usability in demanding pharmaceutical environments. Deviating from these high standards can lead to major downstream headaches, from failed product registrations to wasted clinical development time. We prioritize real, observable quality shifts over merely achieving technical compliance or following fashionable buzzwords in industry publications.
Over the years, we’ve handled both success stories and challenges. Unanticipated increases in regulatory stringency, changing environmental standards, and demand surges from the healthcare sector all shape our approach, sometimes one week at a time. By adapting quickly, making evidence-based process changes, and listening to technical partners, we shield our customers from supply interruption and technical headaches that can derail high-stakes projects.
As therapeutic needs shift and research breakthroughs multiply, cortisone maintains a strong reputation. We see a trend toward exploring synthetic derivatives and advanced delivery forms, especially those making use of nanotechnology or controlled-release matrices. Our R&D department works hand in hand with clients to test new ester derivatives and conjugated forms. Each advancement comes with rigorous data collection and a careful look at real-world performance—not just what looks promising at the lab bench.
Successful partnerships blend customer insight, regulatory know-how, and the ability to reproduce success in a full-scale plant setting. For all its history, cortisone still holds unexploited potential. Much of it stems from careful process optimization, learning by doing, and a culture committed to feeding back lessons learned on the production floor into every revision and improvement.
A career in chemical manufacturing teaches the value of doing the basics well, monitoring every detail, and cultivating relationships built on trust. Cortisone stands as a benchmark compound for our plant—not because it grabs headlines, but because its production encapsulates a discipline of consistency, transparency, and technical excellence. The medical and scientific communities rely on cortisone daily, and our commitment ensures that supply and quality support rather than hinder innovation.
Ongoing refinement of our production process, automation, greener chemistry, and responsive customer support combine to deliver not just a raw material, but a foundation stone for discovery and healing. Every step—selection of raw inputs, process monitoring, packaging, delivery—draws on real feedback. Lessons learned from a thousand batches never go to waste. Behind every shipment is a team who understands the essential place cortisone holds in modern healthcare and research, and who shape their work accordingly, every single day.